Movement Alert|CME Group Falls 3.45% in Regular Trading, Barclays Slashes Target Price as Regulators Move to Block 24/7 Oil Contract

Market Focus07-09

On July 9, CME Group fell 3.45% in regular trading, trading at $235.705/share, with turnover of $141 million. The decline came on dual headwinds from a major analyst downgrade and regulatory pushback against a key growth initiative.

Barclays significantly cut its price target on CME Group to $270 from $316, representing an approximately 14.6% reduction. Simultaneously, the U.S. Commodity Futures Trading Commission is reportedly planning to block CME from using self-certification to fast-track the launch of its around-the-clock oil futures contract, citing concerns that energy markets are not yet prepared to handle a large volume of 24/7 derivative contracts.

The broader financial exchanges sector traded under pressure on the same day, with peer Intercontinental Exchange declining 3.65%. Earlier in the week, UBS had also reduced its CME target from $310 to $260, while Goldman Sachs maintains a Sell rating with a $245 target. The analyst consensus mean target currently stands at $289.47 with an average overweight rating.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment